Table 3.
Cancer antigen peptide specificity of T cell clones generated from TILs isolated from neoplastic tissue of gastric adenocarcinoma patients
| Patients | Peptide-specificity of TIL-derived T cell clones in single patients | |||
|---|---|---|---|---|
| Number of reactive CD4+ clones | Number of reactive CD8+ clones | |||
| 02.CC | 2 | SART3-315 | 2 | SART2-93 |
| 1 | SART3-309 | 1 | CypB-172 | |
| 1 | lck-246 | 1 | UBE2V-85 | |
| 03.CA | 3 | lck-422 | 1 | UBE2V-208 |
| 1 | UBE2V-43 | 1 | CypB-172 | |
| 04.FM | 3 | CypB-172 | 2 | lck-422 |
| 1 | SART3-309 | 1 | SART3-302 | |
| 05.PF | 2 | SART2-93 | 2 | lck-486 |
| 2 | lck-208 | 1 | lck-208 | |
| 1 | lck-488 | 1 | SART2-93 | |
| 06.CAn | 2 | CypB-84 | 2 | CypB-84 |
| 1 | ART4-13 | |||
| 08.DN | 2 | lck-208 | 3 | SART3-109 |
| 2 | SART3-109 | 1 | CypB-84 | |
| 09.BG | 2 | lck-246 | 2 | lck-246 |
| 1 | ART4-13 | 2 | lck-486 | |
| 10.BA | 2 | SART2-93 | 2 | SART3-109 |
| 1 | HNRPL-140 | 2 | HNRPL-501 | |
| 11.BS | 2 | SART2-161 | 1 | SART2-161 |
| 2 | HNRPL-140 | 1 | SART3-315 | |
| 1 | CypB-84 | |||
| 12.BG | 2 | lck-422 | 2 | SART3-302 |
| 1 | SART3-302 | 2 | UBE2V-85 | |
| 1 | UBE2V-85 | |||
| 13.MS | 2 | SART3-302 | 3 | WHSC2-103 |
| 1 | WHSC2-103 | |||
| 14.AC | 2 | HNRPL-501 | 2 | lck-422 |
| 1 | UBE2V-43 | 2 | UBE2V-43 | |
| 1 | UBE2V-85 | |||
| 15.PM | 2 | SART3-302 | 1 | SART3-302 |
| 2 | lck-246 | 2 | lck-246 | |
| 17.MM | 2 | WHSC2-103 | 1 | lck-422 |
| 2 | HNRPL-501 | 2 | HNRPL-501 | |
| 18.SB | 2 | SART3-315 | 2 | SART2-161 |
| 2 | ART4-75 | 2 | ART1-170 | |
| 1 | lck-208 | |||
| 19.AB | 2 | SART2-161 | 1 | SART2-93 |
| 2 | ART4-75 | 1 | SART3-315 | |
| 1 | lck-488 | 1 | lck-208 | |
| 20.BF | 3 | SART3-309 | 2 | SART3-109 |
| 1 | SART2-93 | 1 | CypB-84 | |